A clinical trail to study the effects, safety and efficacy of Polyherbal formulations in patients with mild to moderate psoriasis
Phase 2
Completed
- Registration Number
- CTRI/2010/091/000594
- Lead Sponsor
- APMC college pf pharmaceutical education & Research, Himatnagar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Sex: both male and female.Age 18-70.Newly diagnosed cases of psoriatic patients with mild to moderate psoriasis
Exclusion Criteria
Patients having evidence of extensive disease that require hospitalization and pregnant women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The predefined primary end points were clinical and laboratory evidence to treat psoriasisTimepoint: measurement of PASI,Mean Score, Global assessment by physician and Global assessment by patient
- Secondary Outcome Measures
Name Time Method To see the efficacy of Polyherbal formulations in PsoriasisTimepoint: In terms of sense of well being